Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 7,500 shares at $260.00 ($1.9M) on 2022-11-03, disclosed to the SEC on 2022-11-03.
Seasonal sale ($1.9M) by Director — this insider has traded UTHR in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $240.00 | 2,500 | $600K | 32.0% |
| 2 | $250.01 | 2,500 | $625K | 33.3% |
| 3 | $260.00 | 2,500 | $650K | 34.7% |
| Total | $250.00 avg | 7,500 | $1.9M | 100% |
| Filing → |
| UTHR | SELL | 2026-02-25 | $520K | — | Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |